Bank Julius Baer & Co. Ltd, Zurich Royalty Pharma PLC Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$37.46 - $42.44 $38,733 - $43,882	-1,034 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $325 - $380	9 Added 0.88%	1,034 $37,000
Q2 2021 Jul 23, 2021	BUY	$39.85 - $46.63 $25,902 - $30,309	650 Added 173.33%	1,025 $42,000
Q1 2021 May 10, 2021	SELL	$42.34 - $52.82 $1,058 - $1,320	-25 Reduced 6.25%	375 $16,000
Q4 2020 Feb 24, 2021	BUY	$36.12 - $50.05 $361 - $500	10 Added 2.56%	400 $20,000
Q3 2020 Nov 10, 2020	BUY	$38.56 - $48.36 $15,038 - $18,860	390 New	390 $16,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.